Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

Many commonly prescribed drugs have surprising other uses. Sept. 28, 2010 -- Viagra is well recognized for its primary use. But who knew it would show promise as a cancer fighter, too? Medical ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

England will join Scotland and Wales in widening access to the prostate cancer drug abiraterone, following a public campaign.